GLUL and Hyperammonemia: Therefore, we next investigated the therapeutic efficacy of pharmacologic inhibition of glutamine synthesis or/and NMDA receptor signaling in acute hyperammonemia using the glutamine synthetase inhibitor L-MSO and the NMDA receptor antagonists memantine and ketamine, alone or in combination.